Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting 2020-11-20 21:00
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease 2020-11-20 21:00
CARsgen Therapeutics to Present Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition in December 2020-11-20 19:00
Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID-19 vaccine 2020-11-20 15:31
Qiming's Portfolio Company Antengene Lists on Main Board of HKEX 2020-11-20 14:22
RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease 2020-11-20 07:00
Covis Group Announces Data for Ciraparantag Published in Blood, the Journal of the American Society of Hematology 2020-11-20 01:26
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction 2020-11-19 21:09
RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib 2020-11-19 20:21
VolitionRx Limited to Present COVID-19 Data at MEDICA 2020 2020-11-19 20:00
CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity 2020-11-19 17:13
With Elekta Studio, Elekta brings complete image-guided brachytherapy workflow to a single room 2020-11-19 15:16
ASC40 (TVB-2640) Phase 2 NASH Trial Completed Patient Enrollment in China 2020-11-19 08:30
INEX Innovate's iGene Laboratory announces new personalised medicine genotyping analysis project with Eli Lilly and Company's research unit Lilly Centre for Clinical Pharmacology 2020-11-19 08:00
RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks 2020-11-19 07:00
Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility 2020-11-18 20:00
Change in Use of Proceeds From the Global Offering for Expansion of R&D Portfolio into Hepatitis B Clinical Cure and NASH 2020-11-18 17:00
Cipla launches 'Covi-G' for COVID-19 rapid antibody detection 2020-11-18 16:36
Regent Pacific Announces Important Commercialisation Progress On FORTACIN(TM) / SENSTEND(TM) 2020-11-17 22:09
Russia is considered a highly trusted vaccine manufacturer and almost half of respondents in 11 countries are aware of Sputnik V, a YouGov poll shows 2020-11-17 21:38
1 271 272 273 274 275 412